Skip to main content
Partner ES

The Scientific Foundation of the Spanish Association Against Cancer

FCAECC

Programme phases

2

Funding participation

Joint calls funded by this organisation.

6

Funded projects

Projects linked to this funding organisation.

36
ACCELERATE

Functional precision medicine platform for the treatment of pancreatic cancer

JTC 2024
View project
BileCanMet

Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target

JTC 2022
View project
CAR4PDAC

Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC

JTC 2022
View project
DOPPLER-LC

Development Of Patient-derived organoid PLatform for Evading Resistances in Lung Cancer

JTC 2024
View project
EPILUCAFS

Chronic stress and immunosuppression in lung cancer: focus on epigenetic drivers in cancer-associated fibroblasts

JTC 2023
View project
Euro MDS

An integrated european platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure

JTC 2017
View project
HYDRA

Charting the epigenomic trajectory of progression towards metastatic colorectal cancer

JTC 2023
View project
iMMunocell

Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma

JTC 2016
View project
iParaCyts

Understanding and therapeutically exploiting the immunosuppressive paracrine signalling in the tumour microenvironment of metastatic lesions

JTC 2021
View project
LipidMac

Exploiting lipid-laden macrophages to overcome resistance to cancer immunotherapy

JTC 2021
View project
LIQUIDHOPE

Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastoma

JTC 2017
View project
LUNGOIDS

Subtype-specific Lung Cancer Organoids based on artificial ECM for Precision Oncology: Closing the Gap Between Preclinical Models and Patient Care

JTC 2024
View project
MATTO-GBM

Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma

JTC 2022
View project
METRICs

Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno- therapy Combinations.

JTC 2024
View project
MOLCARUTUC

Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences

JTC 2017
View project
PIXEL

Profiling and functional analysis of the Immune environment of eXtramedullary leukemia rELapses

JTC 2021
View project
PREDICT-BC

Patient-derived models for the Research and Evaluation of Discovery and Innovation in Combination Therapies for Biliary Cancer

JTC 2024
View project
PROSCANEXO

Exploitation of extracellular vesicles for precision diagnostics of prostate cancer

JTC 2016
View project
R.E.ST.ING

Non-invasive prognostic markers for Resected Early-STage NSCLC: role of circulatING and exosomal miRNAs and free circulating DNA

JTC 2016
View project
REACH

Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer

JTC 2023
View project
ReachGLIO

Reaching the heterogeneous vascular landscape of glioblastoma with multifunctional nanomedicines.

JTC 2022
View project
REACTION

Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk

JTC 2023
View project
RISEBrain

Reverting immune suppression to elicit brain metastasis control

JTC 2021
View project
SCIE-PANC

Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer

JTC 2023
View project
SCRAtCH

Microbiota-based screening of anal cancer in HIV-infected individuals

JTC 2016
View project
SeqPerGlio

Intraoperative tumour sequencing for personalized loco-regional drug combination therapy against glioblastoma recurrences

JTC 2024
View project
SIMMBAP

Systemic immunological determinants of tumor evolution and therapy response in BRCA-mutated pancreatic cancer

JTC 2022
View project
SPELCASTER

Standardized Profiling of Epigenetic Loci for decentralized ClAssification of Sinonasal Tumors and idEntification of therapy Response markers

JTC 2023
View project
TANGERINE

Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response

JTC 2021
View project
THRuST

Early detection of relapses in stage II-III colon cancer patients by following a personalized molecular signature from a blood test: THRuST

JTC 2016
View project
TITAN

Novel Cancer Therapy: Inducing Double-strand DNA Breaks to Foster Tumor Cell Death, Antigenicity and Immunotherapy Response in New Personalized Models

JTC 2024
View project
TOPMESO

A TranslatiOnal Platform for de-orphaning malignant pleural MESOthelioma

JTC 2017
View project
TRanSLIT

Targeting ROBOs and SLIT guidance cues in the immunosuppressive stromal context of pancreatic cancer (TRanSLIT)

JTC 2021
View project
TumorOUT

Innovative mRNA vaccine against NSCLC: Designing a platform of targeted polymeric nanoparticles for efficient personalized therapy

JTC 2021
View project
UCIPredict

Circulating tumour microenvironment components as Urothelial Cancer Immunotherapy Response Predictors.

JTC 2021
View project
XPANTHER

Radiothermal-Driven Immune Activation to Tackle Pancreatic Hypoxic Tumors

JTC 2024
View project